Within the past few weeks, the U.S. Food and Drug Administration (FDA or the Agency) has, among other things:
. . . . . . . . . .
​Yesterday, the U.S.
. . . . . . . . . .
Last week, the U.S. House of Representatives (the House) passed by voice vote the FDA Reauthorization Act of 2017 (FDARA or the Act).
. . . . . . . . . .
On June 15, 2017, U.S. Food and Drug Administration (FDA or the Agency) Commissioner Dr.
. . . . . . . . . .
Within the past few weeks, the U.S. Food and Drug Administration (FDA or the Agency) has taken a number of actions that could impact nearly all of the industries it regulates, but in particular, companies in the medical device and food spaces. These actions include:
. . . . . . . . . .
Commission sends letters to 90+ influencers and marketers regarding social media endorsement requirements, enforces Made in the USA claim standards, hosts hearing health workshop, and implements Trump directive.
. . . . . . . . . .
On March 13, 2017, the U.S.
. . . . . . . . . .
With less than three days to go until 2017, the U.S. Food and Drug Administration (FDA or the Agency) shows no signs of slowing down. Here are some of the things the Agency has done in the last few days alone:
. . . . . . . . . .
Within the last week, both the U.S. Senate and the U.S. Food and Drug Administration (FDA or the Agency) have taken significant steps to deregulate a large portion of hearing aid devices.